Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced that the FDA has approved an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results